Abstract
A multistep synthesis of 2-chloro-9-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl) adenine (clofarabine) is described from methyl β-D-ribofuranoside. A new improved method for preparation of 1,2-diacetyl D-ribofuranose derivative was developed via acetolysis of tri-O-pivaloylated D-ribofuranoside and plausible mechanism of the reaction was proposed. Synthesis of 3′,5′-di-O-pivaloyl-2,6-dichloropurine β-D-riboside along with isomeric 2′,5′-di-O-pivaloyl nucleoside was carried out by stereoselective glycosylation reaction of 2,6-dichloropurine with peracylated D-ribofuranose followed by regioselective 2´-O-deacetylation of protected β-ribonucleoside with different bases. Mild C2′-β-fluorination of the purine 3′,5′-di-O-pivaloyl ribonucleoside with an excess of diethylaminosulfur trifluoride afforded protected 2,6-dichloropurine 2′-fluoro β-D-arabinoside as the key intermediate. Efficient route to clofarabine was also investigated using anion glycosylation of 2-chloroadenine potassium salt with the 1-α-bromide and potassium
Author Contributions
Copyright© 2022
Sivets Grigorii, et al.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
Cytotoxic agents relating to a class of modified nucleosides are widely used as effective therapeutics for treatment of cancer Multidirectional mechanism of cytotoxic action of clofarabine, that is not a substrate of adenosine deaminase, includes inhibition of synthesis of DNA and RNA, DNA polymerases, ribonucleotide reductase, and direct induction of cell apoptosis Various chemical and chemoenzymatic methods were explored for synthesis of anticancer nucleosides As part of our efforts on synthesis of biologically active purine nucleosides from sugars, herein we report study of synthetic approaches to clofarabine using regio- and stereoselective transformations of pivaloylated D-ribose derivatives and nucleosides,N-glycosylation reactions of purine bases with available carbohydrate precursors, and novel purine modified analogues.
Materials And Methods
Column chromatography was performed on silica gel 60 H (70-230 mesh; Merck, Darmstadt, Germany), and thin-layer chromatography (TLC) on Merck silica gel aluminum 60 F254 precoated plates. The anhydrous solvents were distilled over CaH2, P2O5 or magnesium prior to the use. All commercially available reagents were used without further purification. 1H, 13C, and 19F NMR spectra were recorded in CDCl3, CD3OD and DMSO-d6 with a Bruker Avance-500-DRX spectrometer at 500.13, 126.76 and 470.59 MHz, respectively. 1H and13C NMR chemical shifts (δ, ppm) are relative to internal chloroform peak (7.26 ppm for 1H and 77.0 for 13C NMR). Chemical shifts are also reported downfield from internal SiMe4 (1H) or external CFCl3 (19F). Splitting patterns were reported as following: s: singlet, d: doublet, t: triplet, m: multiplet.
Results
Synthesis of clofarabine was studied using two synthetic routes from known carbohydrate derivatives. In the first approach, we have employed peracylated D-ribofuranose Carrying out acetolysis of Stereoselective glycosylation of silylated 2,6-dichloropurine with the 1,2-diacetate Selective removal of 2′-O-acetyl group in protected nucleoside a,Determined by b Isolated yield of mixtures of isomeric nucleosides c Yield of isomeric nucleosides from Further, introduction of the C2′-β-fluorine atom via the nucleophilic replacement of an activated C2′-α-hydroxyl of 3′,5′-di-O-pivaloyl ribonucleoside Next, a short approach to clofarabine ( The coupling of Characteristic of the studied glycosylation reactions of the potassium salt of 2-chloroadenine, generated using t-BuOK in 1,2-dimethoxyethane, with 1-α-bromosugar are: i) the anion glycosylation reaction with a small excess of the heterobase proceeds in heterogeneous phase in acetonitrile or a mixture of solvents with different polarities at room temperature with a full conversion of bromosugar to nucleoside products; ii) KBr as additive results in a little increase of β/α-anomeric selectivity towards protected N9-β-nucleoside, and iii) good isolated yield of intermediate benzoylated β-2′F-arabinonucleoside is achieved after selective glycosylation in a binary solvent system and separation of N9-β- and α-glycosylated products by column chromatography on silica gel in detected conditions Deprotection of benzoylated 2′-fluoro β-nucleoside
Entry
Reaction conditions
Ratio of reagent: nucleoside
Reaction time (h)
Ratios of isomeric nucleosides
Rate of conversion of 2´-O-acetate
Yieldb (%)
1
NaHCO3/MeOH
4.3:1
1.8 h
1.80:1.0
73
51
2
Bu2SnO/MeOH
1.1:1
7.2 h
2.00:1.0
71
55
3
Bu2SnO/MeOH
2.1:1
4h50 min
2.44:1.0
85
69
4
NaOCN/MeOH
1.2:1
2h20 min
2.00:1.0
75
66c
5
NaOCN/MeOH
1.9:1
42 min
2.20:1.0
81
67
6
NaOCN/MeOH/THF
1.9:1
46 min
2.20:1.0
79
60
Conclusion
In summary, multistep synthesis of clofarabine and C2′-β-fluorinated purine modified nucleosides was accomplished using regio- and stereoselective reactions of O-pivaloylated D-ribose derivatives and mild fluorination of 3′,5′-di-O-pivaloyl-2,6-dichloropurine riboside containing bulky directing groups with DAST on the key step. Optimized method for preparation of the 1,2-diacetyl D-ribofuranose derivative was developed via acetolysis of tri-O-pivaloylated D-ribofuranose. The intermediate selectively protected purine nucleoside was obtained by stereoselective glycosylation reaction of the 1,2-diacetate with 2,6-dichloropurine followed by regioselective 2´-O-deacetylation of fully protected β-ribonucleoside with different deacylating reagents. The efficient two-step synthetic route to clofarabine via selective anion glycosylation of 2-chloroadenine with 3,5-di-O-benzoyl-2-deoxy-2-fluoro-α-D-arabinofuranosyl bromide in a mixture of solvents is described under mild reaction conditions. N6-isopentyl clofarabine derivative with potential biological activity was prepared by a direct alkylation of the parent nucleoside with 1-methanesulfonyloxy-3-methylbutane in the presence of t-BuOK.